Sinotherapeutics Inc. A Working Capital to Net Assets Ratio
Sinotherapeutics Inc. A working capital to net assets ratio. Sinotherapeutics Inc. A (688247) has a Working Capital to Net Assets ratio of 66.4% as of March 2026. Working capital of CN¥868.33 Million (current assets of CN¥955.31 Million minus current liabilities of CN¥86.98 Million) is measured against net assets of CN¥1.31 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Sinotherapeutics Inc. A tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Sinotherapeutics Inc. A (2020–2025)
Working capital to net assets ratio of Sinotherapeutics Inc. A from 2020 to 2025. This chart shows how Sinotherapeutics Inc. A's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the ratio stands at 66.4%, reflecting working capital of CN¥868.33 Million against net assets of CN¥1.31 Billion CNY. See 688247 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Sinotherapeutics Inc. A Working Capital to Net Assets Ratio by Year (2020–2025)
Sinotherapeutics Inc. A working capital to net assets ratio by year from 2020 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Sinotherapeutics Inc. A from 2020 to 2025, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Sinotherapeutics Inc. A balance sheet assets.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 65.9% | CN¥851.91 Million | CN¥1.29 Billion | CN¥934.87 Million | CN¥82.96 Million | ▼ -2.6 pp |
| 2024 | 68.6% | CN¥873.13 Million | CN¥1.27 Billion | CN¥976.32 Million | CN¥103.19 Million | ▼ -2.6 pp |
| 2023 | 71.2% | CN¥861.29 Million | CN¥1.21 Billion | CN¥952.01 Million | CN¥90.72 Million | ▼ -2.2 pp |
| 2022 | 73.4% | CN¥863.66 Million | CN¥1.18 Billion | CN¥953.71 Million | CN¥90.05 Million | ▼ -1.7 pp |
| 2021 | 75.1% | CN¥529.31 Million | CN¥705.19 Million | CN¥618.83 Million | CN¥89.52 Million | ▲ +3.5 pp |
| 2020 | 71.6% | CN¥402.69 Million | CN¥562.38 Million | CN¥545.86 Million | CN¥143.17 Million | — |